Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-09

Clinical Trial Update: Phase 1 Trial of Na-ASP-2 Hookworm Vaccine in Previously Infected Brazilian Adults [Phase 1]

View source ↗

Summary

Phase 1 trial of Na-ASP-2 Hookworm Vaccine in previously infected Brazilian adults has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Na-ASP-2 Hookworm Vaccine (Na-ASP-2 hookworm vaccine)

Snippet

Sponsor: Albert B. Sabin Vaccine Institute | Conditions: Hookworm Infection | Phase 1 | Status: TERMINATED